REQUEST A DEMO
Total
USD $0.00
Search more companies

Ever Supreme Bio Technology Co., Ltd. (长圣国际生技股份有限公司) (Taiwan, China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Ever Supreme Bio Technology Co., Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Ever Supreme Bio Technology Co., Ltd is a pharmaceutical company specializing in medical and pharmaceutical products. The company is known for its core technologies in immuno-cell and stem cell technology, as well as product development.

Headquarters
4F., No.30, Keya Rd., Daya Dist
Taichung City; Taichung City;

Contact Details: Purchase the Ever Supreme Bio Technology Co., Ltd. (长圣国际生技股份有限公司) report to view the information.

Website: http://www.ever-superme.com.tw

Basic Information
Total Employees:
Purchase the Ever Supreme Bio Technology Co., Ltd. (长圣国际生技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Ever Supreme Bio Technology Co., Ltd. (长圣国际生技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Ever Supreme Bio Technology Co., Ltd. (长圣国际生技股份有限公司) report to view the information.
Incorporation Date:
December 06, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
12.48%
Purchase this report to view the information.
11.75%
Purchase this report to view the information.
1.83%
Purchase this report to view the information.
1.51%
Purchase this report to view the information.
1.41%
Subsidiaries
聖陽生醫國際股份有限公司
100%
Shine-On BioMedical Co., Ltd.
7.23%
Company Performance
Financial values in the chart are available after Ever Supreme Bio Technology Co., Ltd. (长圣国际生技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
12.24%
Total operating revenue
21.4%
Operating Profit/Loss (EBIT)
73.07%
EBITDA
9.76%
Net Profit/Loss for the Period
98.34%
Total Assets
-3.8%
Total Equity
-12.14%
Operating Profit Margin (ROS)
18.38%
Net Profit Margin
20.32%
Return on Equity (ROE)
12.42%
Debt/Equity
2.62%
Quick Ratio
-1.46%
Cash Ratio
-1.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?